Certificate number:RU.77.99.11.003.Е.002049.05.17
Date of registration and renewal:02.05.2017
Dosage form: & nbspTablets weighing 1713 mg.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAA to reduce the risk of functional disorders of female cyclic processes
Composition: & nbspCalcium, vitamin D3, thiamine (B1), riboflavin (B2), pyridoxine (B6), cyanocobolamine (B12), folic acid, biotin, soy isoflavones, E551, E471, E464, E422, E553b, E2171, E172iii
Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, trade network departments as a biologically active food additive for women during pre- and postmenopause - an additional source of calcium, vitamins, soy isoflavones.
Suggested Usage: & nbspAdults take 1 tablet 1 time per day with meals. Duration of admission is 1 month.
Contraindications:Individual intolerance of components.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Keep out of the reach of children at a temperature of no higher than 25 ° C.
Research protocols:In exchange for the certificate of state registration No.RU.77.99.11.003.Е.003836.04.14 of 24.04.2014, the expert opinion of the FGBU Research Institute for Nutrition of RAMS No. 72 / E-324 / b-14 of 20.03.2014.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp29.07.2017
Instructions
Up